News

Peter Schiff Advocates for Selling Bitcoin and Investing in Silver

Peter Schiff Advocates for Selling Bitcoin and Investing in Silver

Schiff Suggests Shifting Investment from Bitcoin to Silver

Economist Peter Schiff recently suggested that Bitcoin holders consider selling a portion of their assets following a recent price rally. He believes that reallocating those funds into silver could be a more profitable strategy, especially as silver prices have been on the rise.

Celebrating Silver's Performance

On social media, Schiff expressed enthusiasm for silver reaching new heights, exceeding $60 per ounce with a nearly 5% increase in a single day. He commented on silver's potential for continued growth after surpassing the $50 long-term resistance.

“As I forecast, once silver took out the $50 long-term double top, it would be off to the races,” proclaimed Schiff, highlighting his belief in the metal's value.

The Silver and Bitcoin Comparison

Bitcoin is facing challenges, losing over 12% of its value in just one month. Conversely, silver has surged by 21% in the same timeframe. This highlights the disparity in their performance, where Bitcoin struggles to maintain its market presence.

Over the last five years, Bitcoin has dramatically outperformed silver, achieving fivefold growth while silver increased by approximately 155%. However, the recent drop in Bitcoin's value against silver has been notable.

In the past year, the number of silver ounces needed to purchase Bitcoin has plummeted from 3,030 to just 1,508.01 ounces. This stark contrast indicates that Bitcoin's value in terms of silver has fallen by more than 50%, whereas its dollar valuation has only decreased by 5.5%.

Schiff's Ongoing Critique of Bitcoin

Schiff remains a prominent critic of Bitcoin, stating recently that the cryptocurrency behaves similarly to silver, with its price declining as silver rises. His critiques emphasize the volatility of Bitcoin, especially during moments when silver shows resilience in the market.

“Bitcoin lacks any utility beyond belief,” Schiff affirms, differentiating it from traditional assets like silver and gold in terms of inherent value.

The Market's Response to Schiff's Analysis

The investment community has been attentive to Schiff's insights. Despite his skepticism towards Bitcoin, opinions vary widely within the crypto sphere. Even Changpeng Zhao, the founder of Binance, remarked that Schiff is on the cusp of acknowledging the potential of Bitcoin but remains resistant.

Frequently Asked Questions

What prompted Peter Schiff to suggest selling Bitcoin?

Schiff believes the recent rally in Bitcoin provides an opportunity for holders to sell and invest in silver, which he sees as a more valuable asset.

How does silver's recent price performance compare to Bitcoin?

While Bitcoin has dropped over 12% in value recently, silver has seen a 21% rise, indicating strong performance for the metal amidst Bitcoin's struggles.

What are Schiff's views on Bitcoin's utility?

Schiff argues that Bitcoin lacks inherent value and only derives worth from popular belief, contrasting it with the tangible value of silver and gold.

How significant is the drop in Bitcoin’s value compared to silver?

Bitcoin's value in silver has decreased by over 50% in the past year, showing a stark decline when compared to its dollar value.

What historical performance differences exist between silver and Bitcoin?

Over five years, Bitcoin has gained fivefold while silver has appreciated by about 155%, although recent trends show silver outperforming Bitcoin.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

FIRSTHABIT Celebrates Inspiring Winners of CHALK AI Math Challenge

Updated Category News Views 103

FIRSTHABIT Concludes the CHALK AI Math Challenge with Enthusiastic Participation At the recent CES 2026, a global technology showcase, FIRSTHABIT marked a remarkable achievement by successfully conducting the CHALK AI Math Challenge, drawing in participants eager to engage with innovative learning tools. This event, held in a vibrant setting at Eureka Park within the...

Continue Reading
Tesla Class Action Lawsuit: Investors Alert and Legal Options

Updated Category News Views 128

Understanding the Tesla Class Action Lawsuit Tesla, Inc. has come under scrutiny with a recent class action lawsuit that could impact many investors. This case primarily involves individuals who purchased Tesla securities during the specified class period. Investors are seeking to recover their losses related to misleading statements made by the company regarding its...

Continue Reading
DNA Nanobots Welcomes Dr. John C. Byrd to Advisory Board

Updated Category News Views 167

Innovative Leadership at DNA Nanobots DNA Nanobots, a pioneering biotechnology firm centered on the development of DNA nanoparticles for targeted therapeutic solutions, is thrilled to announce the addition of Dr. John C. Byrd, M.D. to its Scientific Advisory Board (SAB). Known for his substantial contributions to the field of blood cell cancer therapies, Dr. Byrd's...

Continue Reading
Stock Market Insights: Growth Trends and Economic Indicators

Updated Category News Views 140

Market Reactions to Political Events Recently, there has been significant activity in the stock market following political announcements. A recent framework discussion regarding Greenland led to a surprising impact on stocks. This event sparked an immediate relief rally in which major indexes ended the day up by over 1%. The Russell 2000 index, a benchmark for small-cap...

Continue Reading
ARTHEx Biotech Secures $87 Million to Propel RNA Medicines Forward

Updated Category News Views 315

ARTHEx Biotech Secures $87 Million to Propel RNA Medicines Forward ARTHEx Biotech S.L., a cutting-edge biotechnology company that is at the forefront of developing targeted RNA medicines, has achieved a significant milestone by successfully closing its upsized Series B financing. This funding round, which now totals $87 million, was primarily led by Bpifrance, a new...

Continue Reading